首页 > 最新文献

Apmis最新文献

英文 中文
Inflammatory mediators in bacterial vaginosis: The role of cytokines 细菌性阴道病中的炎症介质:细胞因子的作用
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-02-12 DOI: 10.1111/apm.13380
Yuexin Zhang, Zhi He

BV is a significant concern in women's health with a varying prevalence rate in different cities of China. The condition has been linked to the acquisition of STIs, including HIV and HPV, and can lead to infertility, adverse obstetric outcomes. We conducted a comprehensive literature search in the PubMed. The search was performed from 01/01/2018 to 01/09/2023. The following search terms were used: bacterial vaginosis and cytokine. We also manually searched the reference lists of included studies and relevant reviews to identify additional articles. The presence of Gardnerella spp. can lead to changes in cytokine levels. The immune system of the female reproductive tract consists of various immune cells and molecules that play a vital role in defending against infections. Cytokines, signaling molecules involved in immune cell recruitment and activation, have been identified as potential biomarkers for diagnosing BV and predicting STIs. Current treatments for BV primarily involve antibiotics, but there is a high recurrence rate posttreatment. BV is a complex condition that affects a significant number of women worldwide. The role of cytokines in the onset, progression, and treatment of BV offers promising avenues for future research and potential diagnostic and therapeutic advancements.

阴道炎是妇女健康的一个重要问题,在中国不同城市的发病率各不相同。该病与性传播疾病(包括艾滋病和人乳头瘤病毒)的感染有关,并可导致不孕和不良的产科结果。我们在 PubMed 上进行了全面的文献检索。检索时间为2018年1月1日至2023年9月1日。使用了以下检索词:细菌性阴道病和细胞因子。我们还人工检索了纳入研究和相关综述的参考文献目录,以确定更多文章。加德纳菌的存在会导致细胞因子水平的变化。女性生殖道的免疫系统由各种免疫细胞和分子组成,在抵御感染方面发挥着重要作用。细胞因子是参与免疫细胞招募和激活的信号分子,已被确定为诊断 BV 和预测 STI 的潜在生物标记物。目前治疗 BV 的方法主要是使用抗生素,但治疗后复发率很高。BV 是一种复杂的疾病,影响着全球大量妇女。细胞因子在 BV 的发生、发展和治疗中的作用为未来的研究以及潜在的诊断和治疗进步提供了广阔的前景。
{"title":"Inflammatory mediators in bacterial vaginosis: The role of cytokines","authors":"Yuexin Zhang,&nbsp;Zhi He","doi":"10.1111/apm.13380","DOIUrl":"10.1111/apm.13380","url":null,"abstract":"<p>BV is a significant concern in women's health with a varying prevalence rate in different cities of China. The condition has been linked to the acquisition of STIs, including HIV and HPV, and can lead to infertility, adverse obstetric outcomes. We conducted a comprehensive literature search in the PubMed. The search was performed from 01/01/2018 to 01/09/2023. The following search terms were used: bacterial vaginosis and cytokine. We also manually searched the reference lists of included studies and relevant reviews to identify additional articles. The presence of <i>Gardnerella</i> spp. can lead to changes in cytokine levels. The immune system of the female reproductive tract consists of various immune cells and molecules that play a vital role in defending against infections. Cytokines, signaling molecules involved in immune cell recruitment and activation, have been identified as potential biomarkers for diagnosing BV and predicting STIs. Current treatments for BV primarily involve antibiotics, but there is a high recurrence rate posttreatment. BV is a complex condition that affects a significant number of women worldwide. The role of cytokines in the onset, progression, and treatment of BV offers promising avenues for future research and potential diagnostic and therapeutic advancements.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 4","pages":"245-255"},"PeriodicalIF":2.8,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoimmune vulnerability of beta versus alpha cells might be due to increased 2′,5′ synthetase β细胞相对于α细胞的自身免疫脆弱性可能是由于 2',5'合成酶的增加。
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-02-12 DOI: 10.1111/apm.13384
Karsten Buschard, Martin Haupt-Jorgensen
{"title":"Autoimmune vulnerability of beta versus alpha cells might be due to increased 2′,5′ synthetase","authors":"Karsten Buschard,&nbsp;Martin Haupt-Jorgensen","doi":"10.1111/apm.13384","DOIUrl":"10.1111/apm.13384","url":null,"abstract":"","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 5","pages":"371-372"},"PeriodicalIF":2.8,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Humoral immune response of Galleria mellonella after mono- and co-injection with Hypericum perforatum extract and Candida albicans 金丝桃提取物和白色念珠菌单次注射和联合注射后五倍子的体液免疫反应
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-02-12 DOI: 10.1111/apm.13383
Tülay Turgut Genç, Serhat Kaya, Melih Günay, Çağla Çakaloğlu

Galleria mellonella is used as a model organism to study the innate immune response of insects. In this study, the humoral immune response was assessed by examining phenoloxidase activity, fungal burden, and the expression of phenoloxidase and antimicrobial peptide genes at different time point following separate and combined injections of Hypericum perforatum extract and a nonlethal dose of Candida albicans. The administration of a plant extract at low doses increased phenoloxidase activity, while higher doses had no effect. Similarly, co-injection of a low dose of the extract with the pathogen allowed half of the yeast cells to survive after 24 h. Co-injection of plant extract with the pathogen decreased the phenoloxidase activity at the end of 4 h compared to C. albicans mono-injection. The phenoloxidase gene expressions was reduced in all experimental conditions with respect to the control. When plant extracts and the pathogen were administered together, gallerimycin and hemolin gene expressions were considerably higher compared to mono-injections of plant extracts and the pathogen. The results of this study reveal that gene activation and regulatory mechanisms may change for each immune gene, and that recognition and signaling pathways may differ depending on the involved immunoregulator.

黑腹锦鸡是研究昆虫先天性免疫反应的模式生物。在这项研究中,通过检测酚氧化酶活性、真菌负荷以及酚氧化酶和抗菌肽基因在单独和联合注射贯叶连翘提取物和非致死剂量白色念珠菌后不同时间点的表达情况,对体液免疫反应进行了评估。低剂量的植物提取物增加了酚氧化酶的活性,而高剂量则没有影响。同样,低剂量的植物提取物与病原体共同注射可使一半的酵母细胞在 24 小时后存活下来。与白色念珠菌单一注射相比,植物提取物与病原体共同注射在 4 小时后降低了酚氧化酶的活性。与对照组相比,所有实验条件下酚氧化酶基因表达量都有所降低。当植物提取物和病原体一起注射时,五倍子霉素和血啉基因的表达量比植物提取物和病原体单注射时要高得多。这项研究结果表明,每种免疫基因的基因激活和调控机制都可能发生变化,识别和信号传导途径也可能因所涉及的免疫调节因子不同而不同。
{"title":"Humoral immune response of Galleria mellonella after mono- and co-injection with Hypericum perforatum extract and Candida albicans","authors":"Tülay Turgut Genç,&nbsp;Serhat Kaya,&nbsp;Melih Günay,&nbsp;Çağla Çakaloğlu","doi":"10.1111/apm.13383","DOIUrl":"10.1111/apm.13383","url":null,"abstract":"<p><i>Galleria mellonella</i> is used as a model organism to study the innate immune response of insects. In this study, the humoral immune response was assessed by examining phenoloxidase activity, fungal burden, and the expression of phenoloxidase and antimicrobial peptide genes at different time point following separate and combined injections of <i>Hypericum perforatum</i> extract and a nonlethal dose of <i>Candida albicans</i>. The administration of a plant extract at low doses increased phenoloxidase activity, while higher doses had no effect. Similarly, co-injection of a low dose of the extract with the pathogen allowed half of the yeast cells to survive after 24 h. Co-injection of plant extract with the pathogen decreased the phenoloxidase activity at the end of 4 h compared to <i>C. albicans</i> mono-injection. The phenoloxidase gene expressions was reduced in all experimental conditions with respect to the control. When plant extracts and the pathogen were administered together, gallerimycin and hemolin gene expressions were considerably higher compared to mono-injections of plant extracts and the pathogen. The results of this study reveal that gene activation and regulatory mechanisms may change for each immune gene, and that recognition and signaling pathways may differ depending on the involved immunoregulator.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 5","pages":"358-370"},"PeriodicalIF":2.8,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13383","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virology and safety profile of Molnupiravir at three different doses for treatment of SARS-CoV-2: a systematic review and meta-analysis 三种不同剂量的莫能吡韦治疗SARS-CoV-2的病毒学和安全性概况:系统综述和荟萃分析。
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-01-30 DOI: 10.1111/apm.13373
Mahnoor Sukaina, Syed Hasan Shuja, Syeda Tayyaba Rehan, Sidhant Ochani, Muhammad Sheryar

Molnupiravir is incorporated into the viral genome, thereby increasing errors, mismatching, and misdirecting the viral polymerase thereby, halting viral RNA replication of SARS-CoV-2. Following PRISMA guidelines, a thorough literature search was performed on electronic and medical databases from December 2022 till January 2023. Molnupiravir 800 mg showed significance in creating viral RNA error rate at Day 5 (WMD: 4.91; 95% CI; [1.19, 8.63] p = 0.01; I2 = 0%). Similarly, at 400 mg, Molnupiravir creates an RNA error rate (WMD: 2.27; 95% CI; 2.27 [0.50, 4.65] p = 0.02; I2 = 0%). Furthermore, exhibit a significant outcome for mean change in SARS-CoV-2 RNA viral load from baseline in nasopharyngeal sample at 800 mg Molnupiravir on Day 3 (WMD: −0.22; 95% CI; [−0.35, −0.08] p = 0.002; I2 = 0%), Day 5 (WMD: −0.32; 95% CI; [−0.53, −0.11] p = 0.003; I2 = 24%) and overall pooled analysis (WMD: −0.17; 95% CI; [−0.29, 0.33] p = 0.003; I2 = 32%). Moreover, Molnupiravir 400 mg significantly reduced the incidence of death compared to the placebo group (RR: 0.17; 95% CI; [0.07, 0.43] p = 0.0002; I2 = 0%). Molnupiravir effectively treats SARS-CoV-2 patients by eliminating the virus from the host.

莫诺匹拉韦会融入病毒基因组,从而增加错误、错配和误导病毒聚合酶,从而阻止 SARS-CoV-2 的病毒 RNA 复制。根据 PRISMA 指南,从 2022 年 12 月到 2023 年 1 月,我们在电子和医学数据库中进行了全面的文献检索。莫仑吡韦 800 毫克对第 5 天病毒 RNA 的错误率有显著影响(WMD:4.91;95% CI;[1.19, 8.63] p = 0.01;I2 = 0%)。同样,在 400 毫克时,莫能吡韦会产生 RNA 错误率(WMD:2.27;95% CI;2.27 [0.50,4.65] p = 0.02;I2 = 0%)。此外,在第 3 天服用 800 毫克莫能吡韦的鼻咽样本中,SARS-CoV-2 RNA 病毒载量的平均值与基线相比有显著变化(WMD:-0.22;95% CI;[-0.35, -0.08] p = 0.002;I2 = 0%)、第 5 天(WMD:-0.32;95% CI;[-0.53,-0.11] p = 0.003;I2 = 24%)和总体汇总分析(WMD:-0.17;95% CI;[-0.29,0.33] p = 0.003;I2 = 32%)。此外,与安慰剂组相比,莫能吡韦 400 毫克可显著降低死亡发生率(RR:0.17;95% CI;[0.07, 0.43] p = 0.0002;I2 = 0%)。通过清除宿主体内的病毒,莫诺吡韦可以有效治疗 SARS-CoV-2 患者。
{"title":"Virology and safety profile of Molnupiravir at three different doses for treatment of SARS-CoV-2: a systematic review and meta-analysis","authors":"Mahnoor Sukaina,&nbsp;Syed Hasan Shuja,&nbsp;Syeda Tayyaba Rehan,&nbsp;Sidhant Ochani,&nbsp;Muhammad Sheryar","doi":"10.1111/apm.13373","DOIUrl":"10.1111/apm.13373","url":null,"abstract":"<p>Molnupiravir is incorporated into the viral genome, thereby increasing errors, mismatching, and misdirecting the viral polymerase thereby, halting viral RNA replication of SARS-CoV-2. Following PRISMA guidelines, a thorough literature search was performed on electronic and medical databases from December 2022 till January 2023. Molnupiravir 800 mg showed significance in creating viral RNA error rate at Day 5 (WMD: 4.91; 95% CI; [1.19, 8.63] p = 0.01; <i>I</i><sup>2</sup> = 0%). Similarly, at 400 mg, Molnupiravir creates an RNA error rate (WMD: 2.27; 95% CI; 2.27 [0.50, 4.65] p = 0.02; <i>I</i><sup>2</sup> = 0%). Furthermore, exhibit a significant outcome for mean change in SARS-CoV-2 RNA viral load from baseline in nasopharyngeal sample at 800 mg Molnupiravir on Day 3 (WMD: −0.22; 95% CI; [−0.35, −0.08] p = 0.002; <i>I</i><sup>2</sup> = 0%), Day 5 (WMD: −0.32; 95% CI; [−0.53, −0.11] p = 0.003; <i>I</i><sup>2</sup> = 24%) and overall pooled analysis (WMD: −0.17; 95% CI; [−0.29, 0.33] p = 0.003; <i>I</i><sup>2</sup> = 32%). Moreover, Molnupiravir 400 mg significantly reduced the incidence of death compared to the placebo group (RR: 0.17; 95% CI; [0.07, 0.43] p = 0.0002; <i>I</i><sup>2</sup> = 0%). Molnupiravir effectively treats SARS-CoV-2 patients by eliminating the virus from the host.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 3","pages":"139-151"},"PeriodicalIF":2.8,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139574776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study AGR2 在原发性前列腺癌中的临床意义:一项大规模研究的结果
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-01-30 DOI: 10.1111/apm.13382
Moritz Wambach, Matteo Montani, Josefine Runz, Carsten Stephan, Klaus Jung, Holger Moch, Daniel Eberli, Marit Bernhardt, Oliver Hommerding, Tobias Kreft, Marcus V. Cronauer, Anika Kremer, Thomas Mayr, Stefan Hauser, Glen Kristiansen

Human anterior gradient-2 (AGR2) has been implicated in carcinogenesis of various solid tumours, but the expression data in prostate cancer are contradictory regarding its prognostic value. The objective of this study is to evaluate the expression of AGR2 in a large prostate cancer cohort and to correlate it with clinicopathological data. AGR2 protein expression was analysed immunohistochemically in 1023 well-characterized prostate cancer samples with a validated antibody. AGR2 expression levels in carcinomas were compared with matched tissue samples of adjacent normal glands. AGR2 expression levels were dichotomized and tested for statistical significance. Increased AGR2 expression was found in 93.5% of prostate cancer cases. AGR2 levels were significantly higher in prostate cancer compared with normal prostate tissue. A gradual loss of AGR2 expression was associated with increasing tumour grade (ISUP), and AGR2 expression is inversely related to patient survival, however, multivariable significance is not achieved. AGR2 is clearly upregulated in the majority of prostate cancer cases, yet a true diagnostic value appears unlikely. In spite of the negative correlation of AGR2 expression with increasing tumour grade, no independent prognostic significance was found in this large-scale study.

人类前梯度-2(AGR2)被认为与多种实体瘤的癌变有关,但其在前列腺癌中的表达数据与其预后价值存在矛盾。本研究的目的是评估 AGR2 在大型前列腺癌队列中的表达情况,并将其与临床病理数据相关联。研究人员使用一种经过验证的抗体,对 1023 份特征明确的前列腺癌样本进行了 AGR2 蛋白表达的免疫组化分析。将癌细胞中 AGR2 的表达水平与相邻正常腺体的匹配组织样本进行了比较。AGR2 表达水平被二分,并进行统计学意义检验。在 93.5% 的前列腺癌病例中发现 AGR2 表达增加。与正常前列腺组织相比,前列腺癌的 AGR2 水平明显更高。AGR2表达的逐渐丧失与肿瘤分级(ISUP)的增加有关,AGR2的表达与患者的存活率成反比,但并不具有多变量显著性。AGR2在大多数前列腺癌病例中明显上调,但其真正的诊断价值似乎不大。尽管 AGR2 的表达与肿瘤分级的增加呈负相关,但在这项大规模研究中并未发现其对预后有独立的意义。
{"title":"Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study","authors":"Moritz Wambach,&nbsp;Matteo Montani,&nbsp;Josefine Runz,&nbsp;Carsten Stephan,&nbsp;Klaus Jung,&nbsp;Holger Moch,&nbsp;Daniel Eberli,&nbsp;Marit Bernhardt,&nbsp;Oliver Hommerding,&nbsp;Tobias Kreft,&nbsp;Marcus V. Cronauer,&nbsp;Anika Kremer,&nbsp;Thomas Mayr,&nbsp;Stefan Hauser,&nbsp;Glen Kristiansen","doi":"10.1111/apm.13382","DOIUrl":"10.1111/apm.13382","url":null,"abstract":"<p>Human anterior gradient-2 (AGR2) has been implicated in carcinogenesis of various solid tumours, but the expression data in prostate cancer are contradictory regarding its prognostic value. The objective of this study is to evaluate the expression of AGR2 in a large prostate cancer cohort and to correlate it with clinicopathological data. AGR2 protein expression was analysed immunohistochemically in 1023 well-characterized prostate cancer samples with a validated antibody. AGR2 expression levels in carcinomas were compared with matched tissue samples of adjacent normal glands. AGR2 expression levels were dichotomized and tested for statistical significance. Increased AGR2 expression was found in 93.5% of prostate cancer cases. AGR2 levels were significantly higher in prostate cancer compared with normal prostate tissue. A gradual loss of AGR2 expression was associated with increasing tumour grade (ISUP), and AGR2 expression is inversely related to patient survival, however, multivariable significance is not achieved. AGR2 is clearly upregulated in the majority of prostate cancer cases, yet a true diagnostic value appears unlikely. In spite of the negative correlation of AGR2 expression with increasing tumour grade, no independent prognostic significance was found in this large-scale study.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 4","pages":"256-266"},"PeriodicalIF":2.8,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13382","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139574680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacterial aerobic respiration is a major consumer of oxygen in sputum from patients with acute lower respiratory tract infection. 细菌有氧呼吸是急性下呼吸道感染患者痰液中的主要耗氧量。
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-01-29 DOI: 10.1111/apm.13381
Peter Østrup Jensen, Pernille Olsen, Arnold Matovu Dungu, Gertrud Baunbaek Egelund, Andreas Vestergaard Jensen, Pernille Ravn, Birgitte Lindegaard, Frederik Boëtius Hertz, Thomas Bjarnsholt, Daniel Faurholt-Jepsen, Mette Kolpen

Bacterial aerobic respiration may determine the outcome of antibiotic treatment in experimental settings, but the clinical relevance of bacterial aerobic respiration for the outcome of antibiotic treatment has not been tested. Therefore, we hypothesized that bacterial aerobic respiration is higher in sputum from patients with acute lower respiratory tract infections (aLRTI), than in sputum from patients with chronic LRTI (cLRTI), where the bacteria persist despite antibiotic treatment. The bacterial aerobic respiration was determined according to the dynamics of the oxygen (O2 ) concentration in sputum from aLRTI patients (n = 52). This result was evaluated by comparison to previously published data from patients with cLRTI. O2 consumption resulting in anoxic zones was more frequent in sputum with detected bacterial pathogens. The bacterial aerobic respiration in aLRTI sputum approximated 55% of the total O2 consumption, which was significantly higher than previously published for cLRTI. The bacterial aerobic respiration in sputum was higher in aLRTI patients than previously seen in cLRTI patients, indicating the presence of bacteria with a sensitive physiology in aLRTI. These variations in bacterial physiology between aLRTI patients and cLRTI patients may contribute the huge difference in treatment success between the two patient groups.

在实验环境中,细菌有氧呼吸可能决定抗生素治疗的结果,但细菌有氧呼吸与抗生素治疗结果的临床相关性尚未得到检验。因此,我们假设急性下呼吸道感染(aLRTI)患者的痰中细菌需氧呼吸量高于慢性下呼吸道感染(cLRTI)患者的痰中细菌需氧呼吸量。细菌的有氧呼吸是根据 aLRTI 患者(n = 52)痰液中氧气(O2)浓度的动态变化来确定的。这一结果与之前发表的 cLRTI 患者的数据进行了对比评估。在检测到细菌病原体的痰中,氧气消耗导致缺氧区的情况更为常见。aLRTI 痰液中的细菌有氧呼吸约占总氧气消耗量的 55%,明显高于之前发表的 cLRTI 患者的数据。aLRTI 患者痰液中的细菌有氧呼吸量高于之前在 cLRTI 患者中发现的细菌有氧呼吸量,这表明在 aLRTI 患者中存在生理机能敏感的细菌。aLRTI 患者和 cLRTI 患者在细菌生理方面的这些差异可能是导致两组患者治疗成功率存在巨大差异的原因。
{"title":"Bacterial aerobic respiration is a major consumer of oxygen in sputum from patients with acute lower respiratory tract infection.","authors":"Peter Østrup Jensen, Pernille Olsen, Arnold Matovu Dungu, Gertrud Baunbaek Egelund, Andreas Vestergaard Jensen, Pernille Ravn, Birgitte Lindegaard, Frederik Boëtius Hertz, Thomas Bjarnsholt, Daniel Faurholt-Jepsen, Mette Kolpen","doi":"10.1111/apm.13381","DOIUrl":"https://doi.org/10.1111/apm.13381","url":null,"abstract":"<p><p>Bacterial aerobic respiration may determine the outcome of antibiotic treatment in experimental settings, but the clinical relevance of bacterial aerobic respiration for the outcome of antibiotic treatment has not been tested. Therefore, we hypothesized that bacterial aerobic respiration is higher in sputum from patients with acute lower respiratory tract infections (aLRTI), than in sputum from patients with chronic LRTI (cLRTI), where the bacteria persist despite antibiotic treatment. The bacterial aerobic respiration was determined according to the dynamics of the oxygen (O<sub>2</sub> ) concentration in sputum from aLRTI patients (n = 52). This result was evaluated by comparison to previously published data from patients with cLRTI. O<sub>2</sub> consumption resulting in anoxic zones was more frequent in sputum with detected bacterial pathogens. The bacterial aerobic respiration in aLRTI sputum approximated 55% of the total O<sub>2</sub> consumption, which was significantly higher than previously published for cLRTI. The bacterial aerobic respiration in sputum was higher in aLRTI patients than previously seen in cLRTI patients, indicating the presence of bacteria with a sensitive physiology in aLRTI. These variations in bacterial physiology between aLRTI patients and cLRTI patients may contribute the huge difference in treatment success between the two patient groups.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139569431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune responses to mRNA-based vaccines given as a third COVID-19 vaccine dose in people living with HIV—a literature review 艾滋病病毒感染者对作为第三剂 COVID-19 疫苗的 mRNA 疫苗的免疫反应--文献综述。
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-01-26 DOI: 10.1111/apm.13379
Maria Lodberg Knudsen, Susanne Dam Nielsen, Line Dam Heftdal

People living with HIV (PLWH) were not included in the first efficacy studies of mRNA vaccines against SARS-CoV-2. In this literature review, we investigate evidence of humoral and cellular immunity after a third dose of an mRNA vaccine in PLWH. We performed a literature search in PubMed, Embase, Web of Science and SCOPUS published between 1 January 2020 and 31 December 2022. Selection criteria were studies on immunological responses in PLWH, who were given an mRNA-based vaccine as a third vaccine dose against SARS-CoV-2. Eight articles complied with our selection criteria. All studies found a strong humoral response after the third dose. Five studies investigated cellular immunity and found an increased cellular response after the third vaccine dose in PLWH. No difference in humoral response was observed between PLWH and controls after three doses. However, some of the studies suggested a weaker cellular response among PLWH than in controls, which was associated with lower nadir or current CD4+ T-cell counts. In conclusion, we found evidence of strong humoral immunity in PLWH after receiving an mRNA-based COVID-19 vaccine as a third dose, while the cellular immunity may be impaired compared to controls.

首批针对 SARS-CoV-2 的 mRNA 疫苗疗效研究并未将艾滋病病毒感染者(PLWH)包括在内。在这篇文献综述中,我们调查了艾滋病毒感染者接种第三剂 mRNA 疫苗后产生体液免疫和细胞免疫的证据。我们在 PubMed、Embase、Web of Science 和 SCOPUS 中检索了 2020 年 1 月 1 日至 2022 年 12 月 31 日期间发表的文献。筛选标准是有关接受 mRNA 疫苗作为第三剂 SARS-CoV-2 疫苗的 PLWH 免疫反应的研究。有八篇文章符合我们的选择标准。所有研究都发现,第三剂疫苗接种后会产生强烈的体液免疫反应。五项研究调查了细胞免疫,发现 PLWH 接种第三剂疫苗后细胞反应增强。在接种三剂疫苗后,PLWH 和对照组之间的体液反应没有差异。不过,一些研究表明,与对照组相比,PLWH 患者的细胞反应较弱,这与他们的 CD4+ T 细胞计数较低有关。总之,我们发现有证据表明,PLWH 在接种第三剂基于 mRNA 的 COVID-19 疫苗后会产生较强的体液免疫力,但与对照组相比,细胞免疫力可能会受损。
{"title":"Immune responses to mRNA-based vaccines given as a third COVID-19 vaccine dose in people living with HIV—a literature review","authors":"Maria Lodberg Knudsen,&nbsp;Susanne Dam Nielsen,&nbsp;Line Dam Heftdal","doi":"10.1111/apm.13379","DOIUrl":"10.1111/apm.13379","url":null,"abstract":"<p>People living with HIV (PLWH) were not included in the first efficacy studies of mRNA vaccines against SARS-CoV-2. In this literature review, we investigate evidence of humoral and cellular immunity after a third dose of an mRNA vaccine in PLWH. We performed a literature search in PubMed, Embase, Web of Science and SCOPUS published between 1 January 2020 and 31 December 2022. Selection criteria were studies on immunological responses in PLWH, who were given an mRNA-based vaccine as a third vaccine dose against SARS-CoV-2. Eight articles complied with our selection criteria. All studies found a strong humoral response after the third dose. Five studies investigated cellular immunity and found an increased cellular response after the third vaccine dose in PLWH. No difference in humoral response was observed between PLWH and controls after three doses. However, some of the studies suggested a weaker cellular response among PLWH than in controls, which was associated with lower nadir or current CD4+ T-cell counts. In conclusion, we found evidence of strong humoral immunity in PLWH after receiving an mRNA-based COVID-19 vaccine as a third dose, while the cellular immunity may be impaired compared to controls.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 4","pages":"236-244"},"PeriodicalIF":2.8,"publicationDate":"2024-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13379","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139563180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel sampling technique maintaining the two-dimensional organization of microbes during cultivation from chronic wounds: The Imprint method 在慢性伤口培养过程中保持微生物二维组织的新型取样技术:印记法
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-01-25 DOI: 10.1111/apm.13372
Anne Kristine Servais Iversen, Blaine Gabriel Fritz, Mads Joachim Hansen, Klaus Kirketerp-Møller, Tim Holm Jakobsen, Thomas Bjarnsholt, Mads Lichtenberg

This study aimed to develop and validate “the Imprint method,”, a technique for sampling microbes from chronic wounds while preserving their two-dimensional spatial organization. We used nylon filters to sample bacteria and compared with sampling using Eswabs in 12 patients. The Imprint method identified a mean of 0.93 unique species more than Eswab (4.3 ± 2.2 and 3.4 ± 1.4 unique species, respectively; mean ± SD; n = 30). Accuracy between the Eswab and the Imprint method was 93.2% and in cases of disagreement between methods, Imprint had a higher sensitivity in 6/8 of the most prevalent species. In vitro validation confirmed that the Imprint method could transfer bacterial colonies while replicating their two-dimensional organization and the area covered by bacteria on the plate sampled. Clinical testing demonstrated that the imprint method is a rapid and feasible technique that identified more unique bacterial species than Eswab with a good agreement between methods but that Imprint was better at detecting important pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa. The Imprint method is a novel technique that cultures and records the two-dimensional organization of microbes, providing an alternative or supplement to conventional surface culture using Eswab.

本研究旨在开发和验证 "印记法",这是一种从慢性伤口中采集微生物样本并保留其二维空间组织的技术。我们使用尼龙过滤器对细菌进行采样,并与在 12 名患者中使用 Eswabs 进行采样进行比较。Imprint法比Eswab法平均多鉴定出0.93个独特菌种(分别为4.3 ± 2.2和3.4 ± 1.4个独特菌种;平均值 ± SD;n = 30)。Eswab 和 Imprint 方法的准确度为 93.2%,在两种方法出现分歧的情况下,Imprint 对 6/8 最常见物种的灵敏度更高。体外验证证实,Imprint 方法可以转移细菌菌落,同时复制其二维组织和取样平板上细菌覆盖的面积。临床测试表明,Imprint 方法是一种快速可行的技术,与 Eswab 相比,它能鉴定出更多独特的细菌种类,而且两种方法之间的一致性很好,但 Imprint 在检测金黄色葡萄球菌和铜绿假单胞菌等重要病原体方面更胜一筹。Imprint方法是一种培养和记录微生物二维组织的新型技术,可替代或补充使用Eswab的传统表面培养方法。
{"title":"Novel sampling technique maintaining the two-dimensional organization of microbes during cultivation from chronic wounds: The Imprint method","authors":"Anne Kristine Servais Iversen,&nbsp;Blaine Gabriel Fritz,&nbsp;Mads Joachim Hansen,&nbsp;Klaus Kirketerp-Møller,&nbsp;Tim Holm Jakobsen,&nbsp;Thomas Bjarnsholt,&nbsp;Mads Lichtenberg","doi":"10.1111/apm.13372","DOIUrl":"10.1111/apm.13372","url":null,"abstract":"<p>This study aimed to develop and validate “the Imprint method,”, a technique for sampling microbes from chronic wounds while preserving their two-dimensional spatial organization. We used nylon filters to sample bacteria and compared with sampling using Eswabs in 12 patients. The Imprint method identified a mean of 0.93 unique species more than Eswab (4.3 ± 2.2 and 3.4 ± 1.4 unique species, respectively; mean ± SD; n = 30). Accuracy between the Eswab and the Imprint method was 93.2% and in cases of disagreement between methods, Imprint had a higher sensitivity in 6/8 of the most prevalent species. <i>In vitro</i> validation confirmed that the Imprint method could transfer bacterial colonies while replicating their two-dimensional organization and the area covered by bacteria on the plate sampled. Clinical testing demonstrated that the imprint method is a rapid and feasible technique that identified more unique bacterial species than Eswab with a good agreement between methods but that Imprint was better at detecting important pathogens such as <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>. The Imprint method is a novel technique that cultures and records the two-dimensional organization of microbes, providing an alternative or supplement to conventional surface culture using Eswab.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 3","pages":"210-220"},"PeriodicalIF":2.8,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13372","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139545410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Close monitoring and early intervention: management principles for cystic fibrosis in Denmark 密切监测和早期干预:丹麦囊性纤维化的管理原则。
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-01-24 DOI: 10.1111/apm.13375
Tavs Qvist, Bibi Uhre Nielsen, Hanne Vebert Olesen, Inger Hee Mabuza Mathiesen, Daniel Faurholt-Jepsen, Terese L. Katzenstein, Jannik Helweg-Larsen, Frederikke Rönsholt, Majbritt Jeppesen, Mette Frahm Olsen, Frederik Fouirnaies Buchvald, Kim Gjerum Nielsen, Søren Jensen-Fangel, Tania Pressler, Marianne Skov

Cystic fibrosis (CF) care in Denmark has been characterized by close monitoring and pre-emptive treatment of lung disease and other CF-related complications. Continuous evaluation through data collection and commitment to clinical research has incrementally improved outcomes. This approach has been in line with best practices set forth by European Standards of Care but has also gone beyond Society standards particularly pertaining to early treatment with high-dose combination antimicrobial therapy. Despite a high prevalence of severe CF variants, lung function has been among the best in Europe. In this review, the Danish approach to management of CF prior to the introduction of new CF modulator treatment is explained and benchmarked. Downsides to the Danish approach are discussed and include increased burden of treatment, risk of antimicrobial resistance, side-effects and costs.

在丹麦,囊性纤维化(CF)治疗的特点是对肺部疾病和其他 CF 相关并发症进行密切监测和先期治疗。通过收集数据和致力于临床研究进行持续评估,逐步改善了治疗效果。这种方法符合《欧洲护理标准》规定的最佳实践,但也超越了协会标准,特别是在早期使用大剂量联合抗菌疗法方面。尽管严重 CF 变异的发病率很高,但其肺功能在欧洲一直名列前茅。在这篇综述中,对丹麦在引入新的CF调节剂治疗之前的CF管理方法进行了解释和基准分析。文中讨论了丹麦方法的缺点,包括治疗负担加重、抗菌药耐药性风险、副作用和成本。
{"title":"Close monitoring and early intervention: management principles for cystic fibrosis in Denmark","authors":"Tavs Qvist,&nbsp;Bibi Uhre Nielsen,&nbsp;Hanne Vebert Olesen,&nbsp;Inger Hee Mabuza Mathiesen,&nbsp;Daniel Faurholt-Jepsen,&nbsp;Terese L. Katzenstein,&nbsp;Jannik Helweg-Larsen,&nbsp;Frederikke Rönsholt,&nbsp;Majbritt Jeppesen,&nbsp;Mette Frahm Olsen,&nbsp;Frederik Fouirnaies Buchvald,&nbsp;Kim Gjerum Nielsen,&nbsp;Søren Jensen-Fangel,&nbsp;Tania Pressler,&nbsp;Marianne Skov","doi":"10.1111/apm.13375","DOIUrl":"10.1111/apm.13375","url":null,"abstract":"<p>Cystic fibrosis (CF) care in Denmark has been characterized by close monitoring and pre-emptive treatment of lung disease and other CF-related complications. Continuous evaluation through data collection and commitment to clinical research has incrementally improved outcomes. This approach has been in line with best practices set forth by European Standards of Care but has also gone beyond Society standards particularly pertaining to early treatment with high-dose combination antimicrobial therapy. Despite a high prevalence of severe CF variants, lung function has been among the best in Europe. In this review, the Danish approach to management of CF prior to the introduction of new CF modulator treatment is explained and benchmarked. Downsides to the Danish approach are discussed and include increased burden of treatment, risk of antimicrobial resistance, side-effects and costs.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 4","pages":"223-235"},"PeriodicalIF":2.8,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13375","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139545407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune-microenvironment regulation. 影响 Th17/Treg 基因表达变化和分化的代谢驱动力:对免疫微环境调控的影响。
IF 2.8 4区 医学 Q4 IMMUNOLOGY Pub Date : 2024-01-18 DOI: 10.1111/apm.13378
Carolina Brescia, Salvatore Audia, Alessia Pugliano, Federica Scaglione, Rodolfo Iuliano, Francesco Trapasso, Nicola Perrotti, Emanuela Chiarella, Rosario Amato

The CD4+ T-cell population plays a vital role in the adaptive immune system by coordinating the immune response against different pathogens. A significant transformation occurs in CD4+ cells during an immune response, as they shift from a dormant state to an active state. This transformation leads to extensive proliferation, differentiation, and cytokine production, which contribute to regulating and coordinating the immune response. Th17 and Treg cells are among the most intriguing CD4+ T-cell subpopulations in terms of genetics and metabolism. Gene expression modulation processes rely on and are linked to metabolic changes in cells. Lactylation is a new model that combines metabolism and gene modulation to drive Th17/Treg differentiation and functional processes. The focus of this review is on the metabolic pathways that impact lymphocyte gene modulation in a functionally relevant manner.

CD4+ T 细胞群在适应性免疫系统中发挥着重要作用,它们协调着针对不同病原体的免疫反应。在免疫反应过程中,CD4+细胞会发生重大转变,从休眠状态转变为活跃状态。这种转变导致大量增殖、分化和细胞因子的产生,从而有助于调节和协调免疫反应。Th17 和 Treg 细胞是在遗传学和新陈代谢方面最引人关注的 CD4+ T 细胞亚群之一。基因表达调控过程依赖于细胞的新陈代谢变化并与之相关联。乳化是一种结合新陈代谢和基因调控来驱动 Th17/Treg 分化和功能过程的新模式。本综述的重点是以功能相关的方式影响淋巴细胞基因调控的代谢途径。
{"title":"Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune-microenvironment regulation.","authors":"Carolina Brescia, Salvatore Audia, Alessia Pugliano, Federica Scaglione, Rodolfo Iuliano, Francesco Trapasso, Nicola Perrotti, Emanuela Chiarella, Rosario Amato","doi":"10.1111/apm.13378","DOIUrl":"https://doi.org/10.1111/apm.13378","url":null,"abstract":"<p><p>The CD4<sup>+</sup> T-cell population plays a vital role in the adaptive immune system by coordinating the immune response against different pathogens. A significant transformation occurs in CD4<sup>+</sup> cells during an immune response, as they shift from a dormant state to an active state. This transformation leads to extensive proliferation, differentiation, and cytokine production, which contribute to regulating and coordinating the immune response. Th17 and Treg cells are among the most intriguing CD4<sup>+</sup> T-cell subpopulations in terms of genetics and metabolism. Gene expression modulation processes rely on and are linked to metabolic changes in cells. Lactylation is a new model that combines metabolism and gene modulation to drive Th17/Treg differentiation and functional processes. The focus of this review is on the metabolic pathways that impact lymphocyte gene modulation in a functionally relevant manner.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139490657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Apmis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1